Sana was Co-Founder & Chief Executive Officer at Sigrid Therapeutics, and Head of Business Development at Nanologica. Sana Alajmovic joined Enzymatica in 2026.
Sana Alajmovic is currently
Create your alert
to follow the career of Sana Alajmovic.
In 2010, Sana Alajmovic completed a Bachelor of Science in Business and Economcis at Stockholm School of Economics.
They have also studied at Stockholm School of Economics :
Find more alumni from Stockholm School of Economics
Do you need to know more about Sana Alajmovic? More results.
Report an error
Update the org chart details of Sana Alajmovic.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.